Pharmacy
Home Pharmacy
Esketamine Safe, Effective for Treatment-Resistant Depression
Change in Montgomery-Åsberg Depression Rating Scale score superior for esketamine versus placebo
Immune-Related Adverse Events Up With Checkpoint Inhibitors
Most patients with cancer, autoimmune disease have improvement in events without discontinuing therapy
CVD Risk Up With β2-Agonist, Antimuscarinic Antagonist Start
New use of long-acting β2-agonists, antimuscarinic antagonists tied to higher CVD risk in first 30 days
Improvement Needed in Ob-Gyn Opioid Prescribing Practices
Respondents prescribed median of 26 pills/patient; amount prescribed varied widely by indication
Dasiglucagon Well Tolerated for Severe Hypoglycemia
Early pharmacodynamic response similar to that of GlucaGen, with longer lasting effects plasma glucose
Predictors of Infliximab Response in Ulcerative Colitis Identified
Baseline Mayo Endoscopic Score, CRP/albumin ratio predict treatment response and risk for colectomy
Few Immuno-Oncology Agents Reach ASCO Efficacy Thresholds
Durable survival, response rates rarely recognized as significant by current oncology value frameworks
Pharmaceutical Aids Not Found to Be Helpful for Smoking Cessation
No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence
Increase Seen in Gabapentinoid Use From 2002 to 2015
More than three-fold increase in percentage of adults using gabapentin and/or pregabalin
December 2017 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for December 2017. This roundup includes the latest...
